BioSpace News Archive

Erytech Pharma, a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, is announcing that its Combined Shareholders’ Meeting will be held in French in closed session at 2pm CEST on Friday, June 26, 2020, and also the associated details.

BeiGene, Ltd. announced that the Company will host an investor conference call and webcast on Friday, May 29, 2020 at 8:00 p.m. ET to discuss clinical study results presented at the 2020 American Society of Clinical Oncology Virtual Scientific Program.

Nominates Three Medical Device Industry Veterans – Lonny Carpenter, David Floyd and James Hogan – for Election to the Board of Directors

Wave Life Sciences Ltd., a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present virtually at the Jefferies 2020 Virtual Healthcare Conference on June 4, 2020 at 2:00 p.m. ET.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Jefferies Virtual Healthcare Conference at 11:00 a.m. ET on Tuesday, June 2, 2020. Kevin Gorman, Chief Executive Officer, will present at the conference.

NuVasive, Inc. announced that it intends to offer, subject to market and other considerations, $400.0 million aggregate principal amount of Convertible Senior Notes due 2023 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Dicerna Pharmaceuticals, Inc., a leading developer of investigational ribonucleic acid interference therapeutics, announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present a corporate overview as part of the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 4:30 p.m. ET.

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that its Walmart Marketplace Seller Application has been officially Approved, by global retail giant Walmart Inc. (“Walmart”). In joining Wa

NantKwest, Inc. (NASDAQ: NK) and ImmunityBio, Inc., today announced that Patrick Soon-Shiong, M.D., Chairman and CEO of both companies, will present at the Jefferies Virtual Healthcare Conference on June 3, 2020 at 4:30 pm ET. The presentation will be webcast live and can be accessed through the NantKwest and ImmunityBio websites, NantKwest.com and ImmunityBio.com . An archived replay will be available on the

Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS , announced the launch of eZspand™, an expandable lumbar interbody fusion device.